Remicade (infliximab) Drug Market Report

China Remicade (infliximab) Drug Industry Market Research Report 2023-2029

  • POSTDATE：Oct 04, 2023
  • PAGES：227
  • REPORT CODE：GMM1824195
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Remicade (infliximab) Drug industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Epirus Biopharmaceuticals

    • Samsung Bioepsis

    • Janssen

    • Celltrion Healthcare

    By Type:

    • Brands Drugs

    • Generic Drugs

    By Application:

    • Pediatric Ulcerative Colitis

    • Crohn's Disease

    • Pediatric Crohn's Disease

    • Other

    • Ulcerative Colitis

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Remicade (infliximab) Drug Market Overview 2018-2029

    • 1.1 China Remicade (infliximab) Drug Industry Development Overview

    • 1.2 China Remicade (infliximab) Drug Industry Development History

    • 1.3 China Remicade (infliximab) Drug Industry Market Size (2018-2029)

    • 1.4 China Remicade (infliximab) Drug Market Analysis by Type from Production Side

      • 1.4.1 China Remicade (infliximab) Drug Production Volume, Production Value and Growth Rate of Brands Drugs (2018-2029)

      • 1.4.2 China Remicade (infliximab) Drug Production Volume, Production Value and Growth Rate of Generic Drugs (2018-2029)

    • 1.5 China Remicade (infliximab) Drug Market Analysis by Application from Consumption End

      • 1.5.1 China Remicade (infliximab) Drug Sales Volume, Sales Value and Growth Rate of Pediatric Ulcerative Colitis (2018-2029)

      • 1.5.2 China Remicade (infliximab) Drug Sales Volume, Sales Value and Growth Rate of Crohn's Disease (2018-2029)

      • 1.5.3 China Remicade (infliximab) Drug Sales Volume, Sales Value and Growth Rate of Pediatric Crohn's Disease (2018-2029)

      • 1.5.4 China Remicade (infliximab) Drug Sales Volume, Sales Value and Growth Rate of Other (2018-2029)

      • 1.5.5 China Remicade (infliximab) Drug Sales Volume, Sales Value and Growth Rate of Ulcerative Colitis (2018-2029)

    • 1.6 China Remicade (infliximab) Drug Market Analysis by Region

      • 1.6.1 North China Remicade (infliximab) Drug Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Remicade (infliximab) Drug Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Remicade (infliximab) Drug Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Remicade (infliximab) Drug Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Remicade (infliximab) Drug Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Remicade (infliximab) Drug Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Remicade (infliximab) Drug Market Size and Growth Rate from 2018-2029

    Chapter 2 China Remicade (infliximab) Drug Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Remicade (infliximab) Drug Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Remicade (infliximab) Drug Market Status and Competition Analysis in 2023

      • 2.2.3 China Remicade (infliximab) Drug Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Remicade (infliximab) Drug Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Remicade (infliximab) Drug Industry Development

    Chapter 3 Remicade (infliximab) DrugIndustry Chain Analysis

    • 3.1 Remicade (infliximab) Drug Industry Chain

    • 3.2 Remicade (infliximab) Drug Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Remicade (infliximab) Drug Market

    • 3.3 Remicade (infliximab) Drug Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Remicade (infliximab) Drug Market

    Chapter 4 China Remicade (infliximab) Drug Market, by Type

    • 4.1 China Remicade (infliximab) Drug Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Remicade (infliximab) Drug Total Production Volume and Growth Rate from Production Side

    • 4.5 China Remicade (infliximab) Drug Production Volume and Growth Rate, by Type

      • 4.5.1 China Remicade (infliximab) Drug Production Volume and Growth Rate of Brands Drugs

      • 4.5.2 China Remicade (infliximab) Drug Production Volume and Growth Rate of Generic Drugs

    Chapter 5 China Remicade (infliximab) Drug Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Remicade (infliximab) Drug Total Market Size and Growth Rate from Consumption End

    • 5.5 China Remicade (infliximab) Drug Market Size and Growth Rate, by Application

      • 5.5.1 China Remicade (infliximab) Drug Market Size and Growth Rate of Pediatric Ulcerative Colitis

      • 5.5.2 China Remicade (infliximab) Drug Market Size and Growth Rate of Crohn's Disease

      • 5.5.3 China Remicade (infliximab) Drug Market Size and Growth Rate of Pediatric Crohn's Disease

      • 5.5.4 China Remicade (infliximab) Drug Market Size and Growth Rate of Other

      • 5.5.5 China Remicade (infliximab) Drug Market Size and Growth Rate of Ulcerative Colitis

    Chapter 6 China Remicade (infliximab) Drug Market, by Region

    • 6.1 China Remicade (infliximab) Drug Production Volume and Production Value, by Region

    • 6.2 China Remicade (infliximab) Drug Sales Volume and Sales Value, by Region

    Chapter 7 North China Remicade (infliximab) Drug Market Analysis

    • 7.1 North China Remicade (infliximab) Drug Market, by Type

    • 7.2 North China Remicade (infliximab) Drug Market, by Application

    Chapter 8 Central China Remicade (infliximab) Drug Market Analysis

    • 8.1 Central China Remicade (infliximab) Drug Market, by Type

    • 8.2 Central China Remicade (infliximab) Drug Market, by Application

    Chapter 9 South China Remicade (infliximab) Drug Market Analysis

    • 9.1 South China Remicade (infliximab) Drug Market, by Type

    • 9.2 South China Remicade (infliximab) Drug Market, by Application

    Chapter 10 East China Remicade (infliximab) Drug Market Analysis

    • 10.1 East China Remicade (infliximab) Drug Market, by Type

    • 10.2 East China Remicade (infliximab) Drug Market, by Application

    Chapter 11 Northeast China Remicade (infliximab) Drug Market Analysis

    • 11.1 Northeast China Remicade (infliximab) Drug Market, by Type

    • 11.2 Northeast China Remicade (infliximab) Drug Market, by Application

    Chapter 12 Southwest China Remicade (infliximab) Drug Market Analysis

    • 12.1 Southwest China Remicade (infliximab) Drug Market, by Type

    • 12.2 Southwest China Remicade (infliximab) Drug Market, by Application

    Chapter 13 Northwest China Remicade (infliximab) Drug Market Analysis

    • 13.1 Northwest China Remicade (infliximab) Drug Market, by Type

    • 13.2 Northwest China Remicade (infliximab) Drug Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Epirus Biopharmaceuticals

        • 14.1.1 Epirus Biopharmaceuticals Company Profile

        • 14.1.2 Epirus Biopharmaceuticals Remicade (infliximab) Drug Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Samsung Bioepsis

        • 14.2.1 Samsung Bioepsis Company Profile

        • 14.2.2 Samsung Bioepsis Remicade (infliximab) Drug Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Janssen

        • 14.3.1 Janssen Company Profile

        • 14.3.2 Janssen Remicade (infliximab) Drug Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Celltrion Healthcare

        • 14.4.1 Celltrion Healthcare Company Profile

        • 14.4.2 Celltrion Healthcare Remicade (infliximab) Drug Market Performance

        • 14.4.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Remicade (infliximab) Drug Industry Research Conclusions

    • 15.2 Remicade (infliximab) Drug Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Remicade (infliximab) Drug Industry Market Size (2018-2029)

    • Figure China Remicade (infliximab) Drug Production Volume, Production Value and Growth Rate of Brands Drugs (2018-2029)

    • Figure China Remicade (infliximab) Drug Production Volume, Production Value and Growth Rate of Generic Drugs (2018-2029)

    • Figure China Remicade (infliximab) Drug Sales Volume, Sales Value and Growth Rate of Pediatric Ulcerative Colitis (2018-2029)

    • Figure China Remicade (infliximab) Drug Sales Volume, Sales Value and Growth Rate of Crohn's Disease (2018-2029)

    • Figure China Remicade (infliximab) Drug Sales Volume, Sales Value and Growth Rate of Pediatric Crohn's Disease (2018-2029)

    • Figure China Remicade (infliximab) Drug Sales Volume, Sales Value and Growth Rate of Other (2018-2029)

    • Figure China Remicade (infliximab) Drug Sales Volume, Sales Value and Growth Rate of Ulcerative Colitis (2018-2029)

    • Figure North China Remicade (infliximab) Drug Market Size and Growth Rate from 2018-2029

    • Figure Central China Remicade (infliximab) Drug Market Size and Growth Rate from 2018-2029

    • Figure South China Remicade (infliximab) Drug Market Size and Growth Rate from 2018-2029

    • Figure East China Remicade (infliximab) Drug Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Remicade (infliximab) Drug Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Remicade (infliximab) Drug Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Remicade (infliximab) Drug Market Size and Growth Rate from 2018-2029

    • Figure Remicade (infliximab) Drug Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Remicade (infliximab) Drug Market Share by Type in 2018

    • Figure China Remicade (infliximab) Drug Market Share by Type in 2023

    • Figure China Remicade (infliximab) Drug Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Remicade (infliximab) Drug Production Volume and Growth Rate of Brands Drugs (2018-2023)

    • Figure China Remicade (infliximab) Drug Production Volume and Growth Rate of Generic Drugs (2018-2023)

    • Figure China Remicade (infliximab) Drug Market Share by Application in 2018

    • Figure China Remicade (infliximab) Drug Market Share by Application in 2023

    • Figure China Remicade (infliximab) Drug Total Market Size and Growth Rate from Consumption End

    • Figure China Remicade (infliximab) Drug Market Size and Growth Rate of Pediatric Ulcerative Colitis (2018-2023)

    • Figure China Remicade (infliximab) Drug Market Size and Growth Rate of Crohn's Disease (2018-2023)

    • Figure China Remicade (infliximab) Drug Market Size and Growth Rate of Pediatric Crohn's Disease (2018-2023)

    • Figure China Remicade (infliximab) Drug Market Size and Growth Rate of Other (2018-2023)

    • Figure China Remicade (infliximab) Drug Market Size and Growth Rate of Ulcerative Colitis (2018-2023)

    • Table China Remicade (infliximab) Drug Production Volume by Region (2018-2023)

    • Table China Remicade (infliximab) Drug Production Volume Share by Region (2018-2023)

    • Figure China Remicade (infliximab) Drug Production Volume Share by Region (2018-2023)

    • Table China Remicade (infliximab) Drug Production Value by Region (2018-2023)

    • Table China Remicade (infliximab) Drug Production Value Share by Region (2018-2023)

    • Figure China Remicade (infliximab) Drug Production Value Share by Region (2018-2023)

    • Table China Remicade (infliximab) Drug Sales Volume by Region (2018-2023)

    • Table China Remicade (infliximab) Drug Sales Volume Share by Region (2018-2023)

    • Figure China Remicade (infliximab) Drug Sales Volume Share by Region (2018-2023)

    • Table China Remicade (infliximab) Drug Sales Value by Region (2018-2023)

    • Table China Remicade (infliximab) Drug Sales Value Share by Region (2018-2023)

    • Figure China Remicade (infliximab) Drug Sales Value Share by Region (2018-2023)

    • Table North China Remicade (infliximab) Drug Production Volume by Type (2018-2023)

    • Table North China Remicade (infliximab) Drug Production Volume Share by Type (2018-2023)

    • Figure North China Remicade (infliximab) Drug Production Volume Share by Type (2018-2023)

    • Table North China Remicade (infliximab) Drug Sales Volume by Application (2018-2023)

    • Table North China Remicade (infliximab) Drug Sales Volume Share by Application (2018-2023)

    • Figure North China Remicade (infliximab) Drug Sales Volume Share by Application (2018-2023)

    • Table Central China Remicade (infliximab) Drug Production Volume by Type (2018-2023)

    • Table Central China Remicade (infliximab) Drug Production Volume Share by Type (2018-2023)

    • Figure Central China Remicade (infliximab) Drug Production Volume Share by Type (2018-2023)

    • Table Central China Remicade (infliximab) Drug Sales Volume by Application (2018-2023)

    • Table Central China Remicade (infliximab) Drug Sales Volume Share by Application (2018-2023)

    • Figure Central China Remicade (infliximab) Drug Sales Volume Share by Application (2018-2023)

    • Table South China Remicade (infliximab) Drug Production Volume by Type (2018-2023)

    • Table South China Remicade (infliximab) Drug Production Volume Share by Type (2018-2023)

    • Figure South China Remicade (infliximab) Drug Production Volume Share by Type (2018-2023)

    • Table South China Remicade (infliximab) Drug Sales Volume by Application (2018-2023)

    • Table South China Remicade (infliximab) Drug Sales Volume Share by Application (2018-2023)

    • Figure South China Remicade (infliximab) Drug Sales Volume Share by Application (2018-2023)

    • Table East China Remicade (infliximab) Drug Production Volume by Type (2018-2023)

    • Table East China Remicade (infliximab) Drug Production Volume Share by Type (2018-2023)

    • Figure East China Remicade (infliximab) Drug Production Volume Share by Type (2018-2023)

    • Table East China Remicade (infliximab) Drug Sales Volume by Application (2018-2023)

    • Table East China Remicade (infliximab) Drug Sales Volume Share by Application (2018-2023)

    • Figure East China Remicade (infliximab) Drug Sales Volume Share by Application (2018-2023)

    • Table Northeast China Remicade (infliximab) Drug Production Volume by Type (2018-2023)

    • Table Northeast China Remicade (infliximab) Drug Production Volume Share by Type (2018-2023)

    • Figure Northeast China Remicade (infliximab) Drug Production Volume Share by Type (2018-2023)

    • Table Northeast China Remicade (infliximab) Drug Sales Volume by Application (2018-2023)

    • Table Northeast China Remicade (infliximab) Drug Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Remicade (infliximab) Drug Sales Volume Share by Application (2018-2023)

    • Table Southwest China Remicade (infliximab) Drug Production Volume by Type (2018-2023)

    • Table Southwest China Remicade (infliximab) Drug Production Volume Share by Type (2018-2023)

    • Figure Southwest China Remicade (infliximab) Drug Production Volume Share by Type (2018-2023)

    • Table Southwest China Remicade (infliximab) Drug Sales Volume by Application (2018-2023)

    • Table Southwest China Remicade (infliximab) Drug Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Remicade (infliximab) Drug Sales Volume Share by Application (2018-2023)

    • Table Northwest China Remicade (infliximab) Drug Production Volume by Type (2018-2023)

    • Table Northwest China Remicade (infliximab) Drug Production Volume Share by Type (2018-2023)

    • Figure Northwest China Remicade (infliximab) Drug Production Volume Share by Type (2018-2023)

    • Table Northwest China Remicade (infliximab) Drug Sales Volume by Application (2018-2023)

    • Table Northwest China Remicade (infliximab) Drug Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Remicade (infliximab) Drug Sales Volume Share by Application (2018-2023)

    • Table Epirus Biopharmaceuticals Company Profile

    • Table Epirus Biopharmaceuticals Remicade (infliximab) Drug Revenue, Price and Gross (2018-2023)

    • Table Samsung Bioepsis Company Profile

    • Table Samsung Bioepsis Remicade (infliximab) Drug Revenue, Price and Gross (2018-2023)

    • Table Janssen Company Profile

    • Table Janssen Remicade (infliximab) Drug Revenue, Price and Gross (2018-2023)

    • Table Celltrion Healthcare Company Profile

    • Table Celltrion Healthcare Remicade (infliximab) Drug Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US